SK Life Science Labs
Harshil Dhruv is an experienced professional in the field of biology and drug discovery, currently serving as Director of Biology at SK Life Science Labs since October 2021, after holding the position of Associate Director, Biology. Prior experience includes serving as Sr. Manager of Drug Discovery and Lead of Drug Resistance Biology at Sumitomo Dainippon Pharma Oncology from April 2020 to October 2021, following the merger with Tolero Pharmaceuticals, where Harshil was Group Lead and Sr. Scientist. Earlier roles include Assistant Professor and Research Assistant Professor at TGen - an Affiliate of City of Hope from February 2009 to July 2019, as well as positions at Arizona State University and Utah State University. Harshil holds a Ph.D. and an MS in Biological Engineering from Utah State University and a B.Tech in Dairy Technology from Gujarat Agricultural University. Additionally, training from MIT xPRO was completed in 2020.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU